The anti-apoptotic BCL2 family member MCL1 is also overexpressed in non-GCB DLBCL (~50% at protein level), which could be caused by MCL1 gains or amplification or abnormal activated STAT3 signaling (43). The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.